Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Shares Issued (2016 - 2025)

Sunshine Biopharma (SBFM) has disclosed Shares Issued for 10 consecutive years, with -$17.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Issued fell 999.83% year-over-year to -$17.1 million, compared with a TTM value of $2.3 million through Sep 2025, down 88.07%, and an annual FY2024 reading of $3.6 million, down 73.03% over the prior year.
  • Shares Issued was -$17.1 million for Q3 2025 at Sunshine Biopharma, down from $17.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $29.1 million in Q2 2022 and bottomed at -$30.4 million in Q4 2022.
  • Average Shares Issued over 4 years is $3.3 million, with a median of $3.0 million recorded in 2023.
  • The sharpest move saw Shares Issued surged 129.99% in 2023, then tumbled 999.83% in 2025.
  • Year by year, Shares Issued stood at -$30.4 million in 2022, then skyrocketed by 129.99% to $9.1 million in 2023, then plummeted by 82.23% to $1.6 million in 2024, then plummeted by 1154.08% to -$17.1 million in 2025.
  • Business Quant data shows Shares Issued for SBFM at -$17.1 million in Q3 2025, $17.4 million in Q2 2025, and $355297.0 in Q1 2025.